FDA

News

Hilversum, The Netherlands - April 03, 2014. Image of a touch screen Android phone with social media apps.

Biden likely to ditch Trump's plans to relax digital health ...

President Joe Biden looks likely to ditch the previous administration’s move to create a quicker route to market for digital health products and other devices following the pandemic emergen

News

FDA approves Bayer/Merck & Co heart failure drug

Bayer and Merck & Co’s heart failure drug vericiguat has been approved by the FDA under the brand name Verquvo, in an increasingly competitive market.

News

Will Gottlieb follow up on Trump's promise of a bonfire of regulations?

Biden appoints veteran Woodcock as interim FDA commissioner

Agency veteran Dr Janet Woodcock is the new interim FDA commissioner appointed by president Joe Biden to replace outgoing Trump appointee Stephen Hahn.

News

US eyes permanent change to digital health regulatory path

Developers of digital health tools have benefited from a truncated route to market during the COVID-19 crisis, and that could be made permanent if new FDA guidance is adopted.

News

Boehringer, Lilly’s Jardiance tries to match AZ’s Farxiga wi...

Boehringer and Eli Lilly have moved closer to a heart failure indication for their SGLT2 inhibitor Jardiance, as the FDA starts a fast-track review of the drug in its first use beyond diabe

News

FDA and doctors warn against extending COVID-19 vaccine dose...

Tinkering with the dosing schedule of COVID-19 vaccines runs a “significant risk” to public health, the FDA has warned in a statement after the UK announced plans to prioritise the first do

Biden likely to ditch Trump's plans to relax digital health ...

FDA approves Bayer/Merck & Co heart failure drug

Biden appoints veteran Woodcock as interim FDA commissioner

US eyes permanent change to digital health regulatory path

Boehringer, Lilly’s Jardiance tries to match AZ’s Farxiga wi...

FDA and doctors warn against extending COVID-19 vaccine dose...

Grail cancer test gets lukewarm backing from FDA adcomm

Discover a new era of healthcare panel engagement: Grounded ...

FDA

Editor's Picks